The Massachusetts Life Sciences Center, the agency that manages state investments in the life sciences sector, says that it has awarded a two-year, $7.4 million grant to Organogenesis to support the firm’s expansion in the state. Organogenesis, a Canton, MA-based maker of living cell therapies for damaged tissues, has purchased two buildings in Canton and … Continue reading “Organogenesis Gets $7.4M State Grant”
Seattle Genetics Raises $55M
Seattle Genetics, the Bothell, WA-based developer of cancer drugs, said today it has raised $55.8 million by selling 5.74 million new shares of stock. The company also agreed to sell another 1.17 million shares to Baker Brothers Life Sciences, its largest stockholder, at the same price, which would generate another $11.5 million if approved by … Continue reading “Seattle Genetics Raises $55M”
Web Startup fixR Picks Boston as Ground Zero for Contractor Marketplace
(Updated: Additional information has been added to this story. Please see the editor’s note below.) Call it eBay for contractors—and at least initially for plumbers and carpenters and electricians in the Boston area. FixR, a Spain-based Web startup, has chosen the Hub for the first launch of its online marketplace where contractors bid on jobs … Continue reading “Web Startup fixR Picks Boston as Ground Zero for Contractor Marketplace”
ZymoGenetics Takes Back Full Rights to Cancer Drug Candidate
ZymoGenetics has gotten back full commercial rights to its lead cancer drug in development. The Seattle-based biotech company (NASDAQ: [[ticker:ZGEN]]) is announcing today it is buying back the commercial rights from Denmark-based Novo Nordisk to the IL-21 cancer drug candidate in territories outside North America, which could free up ZymoGenetics to sign a global partnership … Continue reading “ZymoGenetics Takes Back Full Rights to Cancer Drug Candidate”
Zafgen’s Big Idea: Fight Fat by Cutting Off Its Blood Supply
Public health leaders increasingly fret about the epidemic in fatness that has left two-thirds of adults in this country overweight or obese. They urge people to drop the Big Macs and hit the treadmill. But there are some exciting ideas emerging within the biotech and pharmaceutical arenas about what might be done when all that … Continue reading “Zafgen’s Big Idea: Fight Fat by Cutting Off Its Blood Supply”
Biocom or Biopol? San Diego’s Life Sciences Trade Group Aims to Build California Clout in D.C
Joe Panetta is spending more time on flights to Washington D.C. than ever before. Lobbying has always been part of his job in the decade he’s spent running Biocom, the trade association for San Diego’s life sciences industry. But now he’s under instructions from the Biocom board to make doubly sure industry interests are heard … Continue reading “Biocom or Biopol? San Diego’s Life Sciences Trade Group Aims to Build California Clout in D.C”
Riding the Diabetes Wave, Novo Nordisk Sees Chance to Scoop Up Biotech Talent in Seattle
Diabetics can’t just quit taking insulin when the economy takes a nosedive. So if you’re the world’s largest producer of insulin for a chronic, and growing, medical condition, your outlook on life isn’t that bad right now. That’s the enviable position of Novo Nordisk, the Danish drugmaker, and part of the reason why it feels … Continue reading “Riding the Diabetes Wave, Novo Nordisk Sees Chance to Scoop Up Biotech Talent in Seattle”
Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News
There were some interesting M&A developments this past week involving or potentially affecting Massachusetts life sciences firms. Those, and the rest of the week’s news, below. —Regulus Therapeutics, a joint venture of Cambridge, MA-based Alnylam (NASDAQ: [[ticker:ALNY]]) and Carlsbad, CA-based Isis Pharmaceuticals (NASDAQ: [[ticker:ISISI]]), unveiled plans to raise “a very respectable amount” of capital from … Continue reading “Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News”
Websense, Growing Fast, Acquires Spam Filtering Web Service
San Diego’s Websense (NASDAQ: [[ticker:WBSN]]), which develops security software for corporate computer networks and other organizations, says it has acquired Defensio, a spam filtering Web service created by two Canadians. Defensio was founded outside of Montreal, QC, to address the vexing and time-consuming problem of managing spam in the comment areas of blogs and social … Continue reading “Websense, Growing Fast, Acquires Spam Filtering Web Service”
WordStream Inc Obtains $4,000,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c10b871e-59a2-4da7-aa8c-72d8188c2827&Preview=1 Date 1/28/2009 Company Name WordStream Inc Mailing Address 133 Federal St, 5th Floor Boston, MA 02110 Company Description WordStream is a patented, hosted software service that automates most of the painful manual work involved with creating and optimizing both paid and natural search engine marketing; it lets Web marketing professionals realize … Continue reading “WordStream Inc Obtains $4,000,000 Series A Round”
Slacker, Inc. Garners $5,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f81465ed-dc2e-4df7-8c8f-0020b87a3bdc&Preview=1 Date 1/28/2009 Company Name Slacker, Inc. Mailing Address 16935 W. Bernardo Dr. San Diego, CA 92127 Company Description Slacker is a new kind of music company. We deliver personal radio that is customized for every listener. Slacker is effortless to use and the music is accessible at home, in the car, … Continue reading “Slacker, Inc. Garners $5,000,000 New Round”
Omeros Corporation Receives $3,100,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=66468136-28e5-4050-bb29-a34baa294e07&Preview=1 Date 1/28/2009 Company Name Omeros Corporation Mailing Address 1420 Fifth Avenue Seattle, WA 98101 Company Description Omeros recognized that a combination of agents acting on multiple molecular targets may be required for optimal therapeutic effect. Omeros’ product candidates are designed to modulate the molecular mechanisms of pathologic conditions rather than just … Continue reading “Omeros Corporation Receives $3,100,000 New Round”
Fliqz Receives $6,000,000 Series C Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=077f5780-83a3-4060-9be7-1f77ebe500d8&Preview=1 Date 1/28/2009 Company Name Fliqz Mailing Address 2745 10th St Berkeley, CA 94700 Company Description The company operates a video-sharing website. Website http://www.fliqz.com Transaction Type Venture Equity Transaction Amount $6,000,000 Transaction Round Series C Proceeds Purposes The company will use the funds for product development, international expansion and ongoing growth of … Continue reading “Fliqz Receives $6,000,000 Series C Funding Round”
VirtuOz Obtains $11,400,000 Series B Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9b35cf30-e1a2-46f8-ae8b-899bf31993df&Preview=1 Date 1/28/2009 Company Name VirtuOz Mailing Address 512 2nd Street San Francisco, CA 94107 Company Description We are a pioneering software provider of intelligent, multilingual conversational customer support and virtual sales Agents. We transform the customer sales and support experience online by providing Virtual Agents that interact with customers via chat … Continue reading “VirtuOz Obtains $11,400,000 Series B Funding Round”
TriCipher Secures $12,000,000 Series D Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0c5d975c-0425-4845-9b06-bbb224c7b475&Preview=1 Date 1/28/2009 Company Name TriCipher Mailing Address 750 University Avenue Los Gatos, CA 95032 Company Description TriCipher enables business processes and online products to be delivered through web portals at a lower risk, higher convenience and lower cost than ever before. Website http://www.tricipher.com Transaction Type Venture Equity Transaction Amount $12,000,000 Transaction … Continue reading “TriCipher Secures $12,000,000 Series D Funding Round”
The Foundry LLC Obtains $5,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=64180a48-9192-44d4-b103-d8ad138e5d9a&Preview=1 Date 1/28/2009 Company Name The Foundry LLC Mailing Address 199 Jefferson Drive Menlo Park, CA 94025 Company Description The Foundry was co-founded in 1998 by Allan Will and Hanson Gifford, to rapidly turn the best concepts into successful new medical device companies. In addition to inventing new technologies itself, The Foundry … Continue reading “The Foundry LLC Obtains $5,000,000 Series A Financing”
Talari Networks Secures $6,200,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=755e5e71-b1af-4546-b8ac-e982ed8c1293&Preview=1 Date 1/28/2009 Company Name Talari Networks Mailing Address 10250 Palo Vista Road Cupertino, CA 95014 Company Description Talari Network Inc is a networking equipment maker. Website Undisclosed Transaction Type Venture Equity Transaction Amount $6,200,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Menlo Ventures
The Onyx Connection: Seattle-Area Software Firm Spawns 13 CEOs
The Seattle tech family tree spreads far and wide. This morning, my San Diego-based colleague Bruce Bigelow published a story about Covario, a search engine marketing firm backed in part by Seattle’s Voyager Capital. The other Seattle connection there is that Covario’s CEO, Russ Mann, worked for Bellevue, WA-based Onyx Software in the glory days … Continue reading “The Onyx Connection: Seattle-Area Software Firm Spawns 13 CEOs”
Amylin Fourth-Quarter Byetta Sales Drop, Falling Short of Wall Street Estimates
Amylin Pharmaceuticals saw some dark days last fall, and now we can see it in its fourth-quarter earnings report. The San Diego-based biotech company said today sales of its biggest product, exenatide (Byetta) for diabetes, fell almost 8 percent compared with the same period a year earlier. Amylin (NASDAQ: [[ticker:AMLN]]) said after markets closed that … Continue reading “Amylin Fourth-Quarter Byetta Sales Drop, Falling Short of Wall Street Estimates”
Boston Scientific and Rival Settle Suits
Boston Scientific (NSYE:[[ticker:BSX]]), the Natick, MA-based medical devices giant, and Medtronic (NYSE:[[ticker:MDT]]) have settled two lawsuits and agreed to stand down from three others to end all litigation between the two industry rivals in the fields of interventional cardiology and endovascular repair, Boston Scientific announced late this afternoon. The company says terms of the settlements … Continue reading “Boston Scientific and Rival Settle Suits”
Verdiem, Cisco Pair Up to Save Power
Cisco Systems announced today the release of software developed in partnership with Seattle-based Verdiem to automatically save energy in idling computers, phones, networked devices, and eventually, whole buildings. The first version of the product will be available in February as a free upgrade to Cisco’s network switch, to manage energy usage of IP devices. Next … Continue reading “Verdiem, Cisco Pair Up to Save Power”
Innovative Spinal Technologies Jilted, Now Bankrupt, Source Says
Last night we reported that Mansfield, MA-based Innovative Spinal Technologies, a maker of implants to correct degenerative spinal disorders, had gone dark—the company’s website was down and phone calls were going unanswered. A former employee who recently left the company now tells Xconomy that IST shut its doors on Friday, filed for bankruptcy protection, and … Continue reading “Innovative Spinal Technologies Jilted, Now Bankrupt, Source Says”
NitroMed Takes Buyout Offer from Deerfield, Dumps Archemix at the Altar
NitroMed (NASDAQ:[[ticker:NTMD]]), the Lexington, MA-based drug developer that struggled to market a heart failure drug for African-Americans, says it has agreed to be acquired for 80 cents per share in cash by investment firm Deerfield Management. This means NitroMed bailed out of previous agreements to sell BiDil to specialty drugmaker JHP Pharmaceuticals and to merge … Continue reading “NitroMed Takes Buyout Offer from Deerfield, Dumps Archemix at the Altar”
MoneyAisle Passes $100 Million in Deposits
MoneyAisle, the online marketplace for banking products that we profiled shortly after its launch last June, said today that users have now put more than $100 million into certificates of deposit and high-yield savings accounts via the company’s reverse-auction system, in which banks submit competing bids for potential customers’ business. MoneyAisle CEO Mukesh Chatter said … Continue reading “MoneyAisle Passes $100 Million in Deposits”
nLight Raises $10.7M
nLight, the Vancouver, WA-based developer of high-powered semiconductor lasers, said it has raised $10.7 million in the first closing of a new round of equity financing. The cash came from existing investors Oak Investment Partners, Mohr Davidow Ventures, and Menlo Ventures. The money will be used to continue developing integrated laser modules, and boost sales … Continue reading “nLight Raises $10.7M”
Viewers Hunt for Sirtris’ Anti-Aging Drugs After 60 Minutes Story
Apparently, there were still some people who hadn’t heard of Sirtris and its widely publicized anti-aging pills, because Sunday evening’s 60 Minutes story on the Cambridge, MA, biotech firm sparked a surge in Web searches on the company as well as requests for its experimental drugs. The 60 Minutes story on CBS was a recap … Continue reading “Viewers Hunt for Sirtris’ Anti-Aging Drugs After 60 Minutes Story”
Micronics to Roll Out Pocket-Sized Malaria, E. coli Tests This Year
Micronics has been around since 1996, so it hardly qualifies as a startup anymore. But the Redmond, WA-based biotech company has been moving in new directions over the last few years, and is now getting ready to bring its first diagnostic tests to the market. The 28-person company has been in the microfluidics business—the design … Continue reading “Micronics to Roll Out Pocket-Sized Malaria, E. coli Tests This Year”
Genzyme Shares Climb as Competing Kidney Drug Stumbles
Genzyme shares got an unexpected boost this morning. The Cambridge, MA-based biotech company (NASDAQ: [[ticker:GENZ]]) climbed more than $1 a share to $69.20 this morning after a rival, Amgen, said it discontinued development of an experimental treatment that had been posing a threat to Genzyme’s kidney drug franchise. Amgen (NASDAQ: [[ticker:AMGN]]) made the announcement yesterday … Continue reading “Genzyme Shares Climb as Competing Kidney Drug Stumbles”
Pfizer Bid for Wyeth Will Stall Mass. Biotech Deals, CEO Says, State Official Still Sees Growth
A combination of drug giants Pfizer and Wyeth could have many implications for the greater Boston life sciences sector, where both companies employ thousands of workers and have ties to many local biotech firms. News of New York-based Pfizer’s $68 billion proposed acquisition of Wyeth drew mixed reviews from biotech executives and officials in the … Continue reading “Pfizer Bid for Wyeth Will Stall Mass. Biotech Deals, CEO Says, State Official Still Sees Growth”
Top Five Venture Deals From Last Quarter, PetraVM Pulls In $1.5M, Maveron Backs TheWrap, & More Seattle-Area Deals News
After a relatively slow week, the deals picked up a bit in the Northwest during the presidential inauguration week. There was modest activity in software, media, and vaccines. —Xconomy broke the news that PetraVM, a University of Washington software startup, raised $1.5 million in Series A funding from Seattle-based Madrona Venture Group and WRF Capital. … Continue reading “Top Five Venture Deals From Last Quarter, PetraVM Pulls In $1.5M, Maveron Backs TheWrap, & More Seattle-Area Deals News”
Synta, Developer of New Class of Cancer Drugs, Eagerly Awaits Results From Key Trial
Nothing really buys time for patients with terminal forms of melanoma, a type of skin cancer. Not chemotherapy, not targeted antibody drugs, not genetic-based antisense treatments. But Lexington, MA-based Synta Pharmaceuticals should find out within weeks whether or not it has made a breakthrough with a new approach. Synta (NASDAQ: [[ticker:SNTA]]) is on pins and … Continue reading “Synta, Developer of New Class of Cancer Drugs, Eagerly Awaits Results From Key Trial”
San Diego’s Covario Rides Wave of Search Engine Marketing
I didn’t really know what to expect when I sat down with Covario CEO Russ Mann recently over a lunch of fajitas and enchiladas. Many CEOs adopt a kind of taciturn presence to maintain their command authority, but words gush from Mann. Ask a question, and he responds at length. Yet the most-succinct explanation of … Continue reading “San Diego’s Covario Rides Wave of Search Engine Marketing”
Pfizer’s Bid For Wyeth Sends Ripples Through Trubion Pharmaceuticals, Seattle Biotechs
Pfizer rocked the business world yesterday with its $68 billion bid to acquire Madison, NJ-based Wyeth (NYSE: [[ticker:WYE]]), and the ripple effect was felt here in the Northwest. Nobody in town has a bigger stake in this deal than Seattle-based Trubion Pharmaceuticals (NASDAQ: [[ticker:TRBN]]). Trubion’s lead drug candidate for rheumatoid arthritis, TRU-015, has been part … Continue reading “Pfizer’s Bid For Wyeth Sends Ripples Through Trubion Pharmaceuticals, Seattle Biotechs”
Pfizer-Wyeth Combo’s Impact on San Diego Biotech: Bad for Dealmaking, Good for Shareholders
The big story in pharmaceutical-and-biotech land yesterday was New York-based Pfizer’s $68 billion bid to acquire Madison, NJ-based Wyeth (NYSE: [[ticker:WYE]]). Wyeth is known for having more biotech expertise than many of its Big Pharma brethren, generating billions in sales from biotech products like its pneumococcal conjugate vaccine (Prevnar) for infants, as well as its … Continue reading “Pfizer-Wyeth Combo’s Impact on San Diego Biotech: Bad for Dealmaking, Good for Shareholders”
Sloan School Students Survey Boston Startup Scene
In early January, students from MIT’s Sloan School of Management fanned out to companies in Boston, San Francisco, Silicon Valley, and Seattle on the school’s annual Tech Trek. The student-organized job-prospecting event puts budding business moguls soon to receive their MBAs into the same conference rooms with technology entrepreneurs for a download on each company’s … Continue reading “Sloan School Students Survey Boston Startup Scene”
High-Energy Startups: A Report from the Sloan School Tech Trek
“You should visit us more often!” said one of our hosts during the MIT Sloan School of Management’s Massachusetts Tech Trek two weeks ago. The host’s enthusiasm was understandable—the company had just received news of a fresh round of funding in the midst of our visit. But such enthusiasm and energy (pun intended) was clearly … Continue reading “High-Energy Startups: A Report from the Sloan School Tech Trek”
Yes, There Are MBA-Level Startup Jobs Out There: Impressions from the Sloan School Tech Trek
When I first moved from Detroit to Boston a year ago, I discovered a plethora of opportunities in technology companies that are not available anywhere else. Unfortunately, I’ve found that personal connections sometimes matter more than resume credentials in finding a job in the start-up technology space. As a second year MBA student at MIT … Continue reading “Yes, There Are MBA-Level Startup Jobs Out There: Impressions from the Sloan School Tech Trek”
nLight Garners $10,700,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d24ec6ab-034b-4787-9946-514ccd57f4c7&Preview=1 Date 1/27/2009 Company Name nLight Mailing Address 5408 NE 88th Street, Building E Vancouver, WA 98665 Company Description nLight develops and manufactures industry leading high-power semiconductor diode laser components and subsystems. nLight’s products feature unparalleled power, brightness, and reliability and enable a broad range of laser-based products in the industrial, medical, … Continue reading “nLight Garners $10,700,000 New Financing”
CarrierIQ Obtains $20,000,000 Series C Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=23bfb74e-a74b-4f22-a831-4b0ad5df00e4&Preview=1 Date 1/27/2009 Company Name CarrierIQ Mailing Address 1200 Villa Street Mountain View, CA 94041 Company Description Carrier IQ eliminates guesswork by automatically providing accurate, real-time data direct from the source—your customers’ handsets. Our powerful platform aggregates, analyzes and delivers that data via easy-to-use web applications that help wireless carriers make smart … Continue reading “CarrierIQ Obtains $20,000,000 Series C Financing”
NASA Astronaut Remembrance Weekend: Bonnie Dunbar Special Program
In conjunction with NASA’s Day of Remembrance and the Museum’s exhibit The Berlin Airlift-A Legacy of Friendship, the President and CEO of The Museum of Flight and retired NASA Astronaut, Dr. Bonnie J. Dunbar will present a special program at the Museum on Feb. 1 at 2 p.m. The lecture is part of “NASA Astronaut … Continue reading “NASA Astronaut Remembrance Weekend: Bonnie Dunbar Special Program”
Alliance of Angels: 10-Minute Pitch Clinic
Alliance of Angels is hosting its 10 Minute Pitch Clinic, an educational event tailored specifically to entrepreneurs on how to effectively pitch a startup business plan to angel investors. The clinic will include an overview of the Alliance of Angels’ rigorous four-step process, in-depth review of the components of a good pitch, and, an interactive … Continue reading “Alliance of Angels: 10-Minute Pitch Clinic”
Buying Time With Suspended Animation: Dana Miller of the Hutch
Dana L. Miller, a researcher at the Fred Hutchinson Cancer Research Center in Seattle, will give a talk about “Buying Time with Suspended Animation” as part of the regular Science on Tap lecture series. For more information on Science on Tap, click here.
What’s Up at Innovative Spinal Technologies? Everything Seems Down
When nobody answers a company’s phones and its website turns into a big fat 404 error, it can’t be a good sign. That seems to be the situation at Innovative Spinal Technologies, a Mansfield, MA, medical device company that, according to our calculations, had raised some $63 million in venture and private equity funding to … Continue reading “What’s Up at Innovative Spinal Technologies? Everything Seems Down”
Maveron Funds TheWrap.com
Seattle-based Maveron has led an investment in TheWrap.com, a Hollywood, CA-based news site covering the entertainment and media business. Financial terms of the deal were not disclosed. TheWrap.com debuted today.
Sequenom Buys Small Diagnostic Maker
Sequenom, the San Diego-based developer of a non-invasive prenatal test for Down Syndrome, said today it has acquired Ann Arbor, MI-based SensiGen for $8.7 million, plus potential milestones. The deal gives Sequenom (NASDAQ: [[ticker:SQNM]]) molecular diagnostics for human papillomavirus, lupus, chronic kidney disease, and inflammatory bowel disease. The purchase is part of Sequenom’s strategy to … Continue reading “Sequenom Buys Small Diagnostic Maker”
Beacon Power, National Grid Ink Deal
Beacon Power (NASDAQ: [[ticker:BCON]]), a Tyngsboro, MA, company developing flywheel-based energy storage systems that help electrical grid operators smooth out the supply of power, announced today that it has signed an information-sharing agreement with National Grid (NYSE: [[ticker:NGG]]), the UK-based utility that supplies power to much of the Northeastern United States. Under the agreement, National … Continue reading “Beacon Power, National Grid Ink Deal”
550 Layoffs at Brooks Automation
Chelmsford, MA-based Brooks Automation (NASDAQ: [[ticker:BRKS]]), which makes robotic equipment used in the manufacturing of semiconductors, storage media, and flat panel displays, said today that a restructuring plan initiated as a response to deteriorating sales resulted in about 200 layoffs in the final quarter of 2008, and will lead to another 350 layoffs in the … Continue reading “550 Layoffs at Brooks Automation”
Bill Gates’s First Annual Letter on Life at the Foundation: “I Love the Work”
Bill Gates says he loves his new job at his charitable foundation. The co-founder of Microsoft says so this morning in his first annual letter, posted online, sizing up his nonprofit work. Gates left his full-time job at Microsoft in June, to devote his full attention to the Bill & Melinda Gates Foundation, the world’s … Continue reading “Bill Gates’s First Annual Letter on Life at the Foundation: “I Love the Work””
Israel’s Modu Gets Venture Funding From Qualcomm
Israel’s daily business newspaper Calcalist is reporting that San Diego’s Qualcomm has invested $7 million in modu, a modular mobile phone maker headed by the inventor of the USB flash drive. Founder and CEO Dov Moran started modu in 2007 in Kfar-Saba, Israel, after selling his previous company, msystems, to SanDisk in 2006 for $1.6 … Continue reading “Israel’s Modu Gets Venture Funding From Qualcomm”
Top Three Trends in Angel Capital, from Seattle Investor Geoff Entress
Have angel investors become the new venture capitalists? Earlier this month, my colleague Wade Roush reported on a presentation by James Geshwiler of the Boston-area group CommonAngels about the changing nature of angel investing. Between Geshwiler’s comments and what I’ve been hearing around Seattle, it seems like the dynamic between angels and VCs has shifted … Continue reading “Top Three Trends in Angel Capital, from Seattle Investor Geoff Entress”